Yale Bulletin and Calendar

February 29, 2008|Volume 36, Number 20


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


This image shows the virus (in green)
attacking the tumor (in red).



Yale-engineered virus can attack brain tumors

A laboratory-engineered virus that can find its way through the vascular system and kill deadly brain tumors has been developed by Yale School of Medicine researchers, it was reported Feb. 20 in the Journal of Neuroscience.

Each year 200,000 people in the United States are diagnosed with a brain tumor, and metastatic tumors and glioblastomas make up a large part of these tumors. There currently is no cure for these types of tumors, and they generally result in death within months.

Anthony van den Pol, professor of neurosurgery, says the current treatments — including chemotherapy, radiation and surgery — can prolong life for a few months, but generally fail because they don’t eliminate all of the cancer cells.

To test their tumor-targeting virus, van den Pol and his team transplanted tumor tissue from human or mouse brains into the brains of mice. They then inoculated the mice with a lab-created vesicular stomatitis virus, a replicating virus distantly related to the rabies virus.

“Three days after inoculation, the tumors were completely or almost completely infected with the virus and the tumor cells were dying or dead,” van den Pol says. “We were able to target different types of cancer cells. Within the same time frame, normal mouse brain cells or normal human brain cells transplanted into mice were spared. This underlines the virus’ potential therapeutic value against multiple types of brain cancers.”

The team also tested targeting brain tumors with the virus through the olfactory nerve and found it led to complete infection of the tumor. After infection, the tumor cells disappeared from the olfactory bulb, van den Pol says.

Co-authors include lead author Koray Özduman, Guido Wollmann and Joseph Piepmeier.

By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Yale-engineered virus can attack brain tumors

Trustees set next steps in residential college expansion

Going back to the ‘basics’ of medicine on the wards of Uganda

New center promotes the study of Hellenic culture and civilization

Study to examine Internet-based programs for diabetic children

Study offers insight into possible cause of lymphoma

Lorimer lauded for contributions to corporate boards

Yale chemist honored for contributions to teaching . . .

Show documents people and fauna of the ‘New World’

‘Chronicler of American life’ is next Maynard Mack lecturer

Contemporary images of the Virgin Mary are featured in . . .

Symposium will explore human rights issues related to . . .

Police Academy for citizens to be held this spring

Arabic music past and present is explored in new exhibition

Chinese ‘Year of the Rat’ celebrated at Yale

Hundreds of schoolchildren will gather in Yale ‘castle’ . . .

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home